Phase 3 Hypertension clinical trials

17 recruiting Phase 3 hypertension studies in the US. What trial phases mean

Other phases

RecruitingPhase 3NCT07181109

Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease

Sponsor: Alnylam Pharmaceuticals

Birmingham, AL · Fairhope, AL · +270 more sites

RecruitingPhase 3NCT07179380

Efficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

Sponsor: Insmed Incorporated

Phoenix, AZ · Fresno, CA · Los Angeles, CA · +16 more sites

RecruitingPhase 3NCT06822738

A Study to Assess Adverse Events and Effectiveness of Gel Stent (XEN63) Implantation Using Ab Interno and Ab Externo Approaches in Adult Participants With Glaucoma

Sponsor: AbbVie

Glendale, AZ · Culver City, CA · Petaluma, CA · +26 more sites

RecruitingPhase 3NCT05470205

Noninvasive Subharmonic Aided Pressure Estimation of Portal Hypertension; Renewal

Sponsor: Thomas Jefferson University

Philadelphia, PA

RecruitingPhase 3NCT06742723

A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure

Sponsor: AstraZeneca

Fairhope, AL · Surprise, AZ · Tucson, AZ · +130 more sites

RecruitingPhase 3NCT07661329

A Study to Evaluate Efficacy and Safety of YSBP Compared to Lumigan in Patients With Glaucoma or Ocular Hypertension

Sponsor: YS Life Science Co., Ltd.

Beverly Hills, CA · Inglewood, CA · Newport Beach, CA · +11 more sites

RecruitingPhase 3NCT06408181

APPLE: Aspirin to Prevent Pregnancy Loss and Preeclampsia

Sponsor: University of Pennsylvania

Philadelphia, PA

RecruitingPhase 3NCT04967989

Clarifying the Optimal Application of SLT Therapy Trial

Sponsor: University of Pittsburgh

Laguna Hills, CA · Pasadena, CA · Sacramento, CA · +25 more sites

RecruitingPhase 3NCT07234032

An Open-Label Extension Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

Sponsor: Insmed Incorporated

Naples, FL · Bend, OR

RecruitingPhase 3NCT07495852

Trial to Evaluate the Safety and Efficacy of the Second Generation Travoprost Intracameral Implant

Sponsor: Glaukos Corporation

Dothan, AL

RecruitingPhase 3NCT05551104

Safest Choice of Antihypertensive Regimen for Postpartum Hypertension

Sponsor: Loma Linda University

Loma Linda, CA

RecruitingPhase 3NCT07218783

Evaluation of the Safety and Efficacy of the Bimatoprost Implant System Used in Combination With the SpyGlass IOL Compared to Timolol Ophthalmic Solution (Rhine)

Sponsor: SpyGlass Pharma, Inc.

Houston, TX

RecruitingPhase 3NCT07218796

Evaluation of the Safety and Efficacy of the Bimatoprost Implant System Used in Combination With the SpyGlass IOL Compared to Timolol Ophthalmic Solution (Rhone)

Sponsor: SpyGlass Pharma, Inc.

San Antonio, TX

RecruitingPhase 3NCT07187206

Safety and Efficacy of FETO in CDH Phase III

Sponsor: Children's Hospital Medical Center, Cincinnati

Cincinnati, OH

RecruitingPhase 3NCT06941441

PAH Exercise Study

Sponsor: University of Washington

Seattle, WA

RecruitingPhase 3NCT05401357

Bioequivalence Study With Clinical Endpoint Comparing Bimatoprost Ophthalmic Solution 0.01% and LUMIGAN® in the Treatment of Chronic Open-Angle Glaucoma or Ocular Hypertension in Both Eyes.

Sponsor: Amneal Pharmaceuticals, LLC

Newport Beach, CA · Petaluma, CA · New Smyrna Beach, FL · +6 more sites

Not yet recruitingPhase 3NCT07220902

Levetiracetam Compared to Magnesium Sulfate for Prevention of Eclamptic Seizure

Sponsor: Nebraska Methodist Health System

Omaha, NE

Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.